内镜治疗后复发食管癌的监测和管理建议。
Recommendations for Surveillance and Management of Recurrent Esophageal Cancer Following Endoscopic Therapies.
机构信息
Department of Cardiothoracic Surgery, The University of Pittsburgh School of Medicine and the University of Pittsburgh Medical Center, 200 Lothrop Street, Suite C800, Pittsburgh, PA 15213, USA.
Department of Surgery, Section of Thoracic Surgery, Albany Medical Center, 43 New Scotland Avenue, MC-50, R-113, Albany, NY 12208, USA.
出版信息
Surg Clin North Am. 2021 Jun;101(3):415-426. doi: 10.1016/j.suc.2021.03.004.
With advancing endoscopic technology and screening protocols for Barrett disease, more patients are being diagnosed with early-stage esophageal cancer. These early-stage patients may be amendable to endoscopic therapies, such as endomucosal resection and ablation. These therapies may minimize morbidity, but the elevated risk of recurrence cannot be overlooked. This article reports outcomes and recommendations for surveillance and management of recurrent esophageal cancer following endoscopic therapies.
随着内镜技术的进步和 Barrett 病的筛查方案的实施，越来越多的患者被诊断为早期食管癌。这些早期患者可能适合接受内镜治疗，如黏膜内切除术和消融术。这些治疗方法可以降低发病率，但不能忽视复发的高风险。本文报告了内镜治疗后复发食管癌的结局和监测管理建议。
Zotero 插件